Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 203

1.

Widespread Disruption of Functional Brain Organization in Early-Onset Alzheimer's Disease.

Adriaanse SM, Binnewijzend MA, Ossenkoppele R, Tijms BM, van der Flier WM, Koene T, Smits LL, Wink AM, Scheltens P, van Berckel BN, Barkhof F.

PLoS One. 2014 Jul 31;9(7):e102995. doi: 10.1371/journal.pone.0102995. eCollection 2014.

PMID:
25080229
[PubMed - as supplied by publisher]
2.

SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease.

Ramirez A, van der Flier WM, Herold C, Ramonet D, Heilmann S, Lewczuk P, Popp J, Lacour A, Drichel D, Louwersheimer E, Kummer MP, Cruchaga C, Hoffmann P, Teunissen C, Holstege H, Kornhuber J, Peters O, Naj AC, Chouraki V, Bellenguez C, Gerrish A; International Genomics of Alzheimer's Project (IGAP); Alzheimer's Disease Neuroimaging Initiative (ADNI), Heun R, Frölich L, Hüll M, Buscemi L, Herms S, Kölsch H, Scheltens P, Breteler MM, Rüther E, Wiltfang J, Goate A, Jessen F, Maier W, Heneka MT, Becker T, Nöthen MM.

Hum Mol Genet. 2014 Jul 15. pii: ddu372. [Epub ahead of print]

PMID:
25027320
[PubMed - as supplied by publisher]
3.

Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer¿s disease correlates with pathology.

Rosenberger A, Rozemuller A, van der Flier WM, Scheltens P, van der Vies SM, Hoozemans J.

Acta Neuropathol Commun. 2014 Jul 16;2(1):79. [Epub ahead of print]

PMID:
25027113
[PubMed - as supplied by publisher]
Free Article
4.

Brain volume and white matter hyperintensities as determinants of cerebral blood flow in Alzheimer's disease.

Benedictus MR, Binnewijzend MA, Kuijer JP, Steenwijk MD, Versteeg A, Vrenken H, Scheltens P, Barkhof F, van der Flier WM, Prins ND.

Neurobiol Aging. 2014 Jun 13. pii: S0197-4580(14)00402-3. doi: 10.1016/j.neurobiolaging.2014.06.001. [Epub ahead of print]

PMID:
25018106
[PubMed - as supplied by publisher]
5.

Distinct perfusion patterns in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies.

Binnewijzend MA, Kuijer JP, van der Flier WM, Benedictus MR, Möller CM, Pijnenburg YA, Lemstra AW, Prins ND, Wattjes MP, van Berckel BN, Scheltens P, Barkhof F.

Eur Radiol. 2014 Jul 5. [Epub ahead of print]

PMID:
24996793
[PubMed - as supplied by publisher]
6.

The association of angiotensin-converting enzyme with biomarkers for Alzheimer's disease.

Jochemsen HM, Teunissen CE, Ashby EL, van der Flier WM, Jones RE, Geerlings MI, Scheltens P, Kehoe PG, Muller M.

Alzheimers Res Ther. 2014 May 15;6(3):27. doi: 10.1186/alzrt257. eCollection 2014.

PMID:
24987467
[PubMed]
Free PMC Article
7.

Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.

Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V, Hernandez DG, Nalls MA, Clark LN, Honig LS, Marder K, Van Der Flier WM, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Compta Y, Revesz T, Lees A, Cairns N, Halliday GM, Mann D, Pickering-Brown S, Dickson DW, Singleton A, Hardy J.

Hum Mol Genet. 2014 Jun 27. pii: ddu334. [Epub ahead of print]

PMID:
24973356
[PubMed - as supplied by publisher]
Free Article
8.

Disturbed phase relations in white matter hyperintensity based vascular dementia: An EEG directed connectivity study.

van Straaten EC, den Haan J, de Waal H, van der Flier WM, Barkhof F, Prins ND, Stam CJ.

Clin Neurophysiol. 2014 Jun 4. pii: S1388-2457(14)00293-4. doi: 10.1016/j.clinph.2014.05.018. [Epub ahead of print]

PMID:
24969377
[PubMed - as supplied by publisher]
9.

The Influence of Co-Morbidity and Frailty on the Clinical Manifestation of Patients with Alzheimer's Disease.

Oosterveld SM, Kessels RP, Hamel R, Ramakers IH, Aalten P, Verhey FR, Sistermans N, Smits LL, Pijnenburg YA, van der Flier WM, Olde Rikkert MG, Melis RJ.

J Alzheimers Dis. 2014 Jun 2. [Epub ahead of print]

PMID:
24898646
[PubMed - as supplied by publisher]
10.

Comparison of Simplified Parametric Methods for Visual Interpretation of 11C-Pittsburgh Compound-B PET Images.

Zwan MD, Ossenkoppele R, Tolboom N, Beunders AJ, Kloet RW, Adriaanse SM, Boellaard R, Windhorst AD, Raijmakers P, Adams H, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN.

J Nucl Med. 2014 Jun 4. pii: jnumed.114.139121. [Epub ahead of print]

PMID:
24898026
[PubMed - as supplied by publisher]
11.

Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.

Kester MI, Goos JD, Teunissen CE, Benedictus MR, Bouwman FH, Wattjes MP, Barkhof F, Scheltens P, van der Flier WM.

JAMA Neurol. 2014 Jul 1;71(7):855-62. doi: 10.1001/jamaneurol.2014.754.

PMID:
24818585
[PubMed - in process]
12.

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease.

Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chételat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM, Glodzik L, van Harten AC, de Leon MJ, McHugh P, Mielke MM, Molinuevo JL, Mosconi L, Osorio RS, Perrotin A, Petersen RC, Rabin LA, Rami L, Reisberg B, Rentz DM, Sachdev PS, de la Sayette V, Saykin AJ, Scheltens P, Shulman MB, Slavin MJ, Sperling RA, Stewart R, Uspenskaya O, Vellas B, Visser PJ, Wagner M; Subjective Cognitive Decline Initiative (SCD-I) Working Group.

Alzheimers Dement. 2014 May 3. pii: S1552-5260(14)00002-8. doi: 10.1016/j.jalz.2014.01.001. [Epub ahead of print]

PMID:
24798886
[PubMed - as supplied by publisher]
13.

Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions.

Ossenkoppele R, van der Flier WM, Verfaillie SC, Vrenken H, Versteeg A, van Schijndel RA, Sikkes SA, Twisk J, Adriaanse SM, Zwan MD, Boellaard R, Windhorst AD, Barkhof F, Scheltens P, Lammertsma AA, van Berckel BN.

Neurology. 2014 May 20;82(20):1768-75. doi: 10.1212/WNL.0000000000000432. Epub 2014 Apr 18.

PMID:
24748672
[PubMed - indexed for MEDLINE]
14.

Single-subject gray matter graph properties and their relationship with cognitive impairment in early- and late-onset Alzheimer's disease.

Tijms BM, Yeung HM, Sikkes SA, Möller C, Smits LL, Stam CJ, Scheltens P, van der Flier WM, Barkhof F.

Brain Connect. 2014 Jun;4(5):337-46. doi: 10.1089/brain.2013.0209.

PMID:
24735020
[PubMed - in process]
15.

The cerebrospinal fluid "Alzheimer profile": Easily said, but what does it mean?

Duits FH, Teunissen CE, Bouwman FH, Visser PJ, Mattsson N, Zetterberg H, Blennow K, Hansson O, Minthon L, Andreasen N, Marcusson J, Wallin A, Rikkert MO, Tsolaki M, Parnetti L, Herukka SK, Hampel H, De Leon MJ, Schröder J, Aarsland D, Blankenstein MA, Scheltens P, van der Flier WM.

Alzheimers Dement. 2014 Apr 7. pii: S1552-5260(14)00029-6. doi: 10.1016/j.jalz.2013.12.023. [Epub ahead of print]

PMID:
24721526
[PubMed - as supplied by publisher]
16.

The structure of the geriatric depressed brain and response to electroconvulsive therapy.

Oudega ML, van Exel E, Stek ML, Wattjes MP, van der Flier WM, Comijs HC, Dols A, Scheltens P, Barkhof F, Eikelenboom P, van den Heuvel OA.

Psychiatry Res. 2014 Apr 30;222(1-2):1-9. doi: 10.1016/j.pscychresns.2014.03.002. Epub 2014 Mar 14.

PMID:
24686000
[PubMed - in process]
17.

The Rest-Activity Rhythm and Physical Activity in Early-Onset Dementia.

Hooghiemstra AM, Eggermont LH, Scheltens P, van der Flier WM, Scherder EJ.

Alzheimer Dis Assoc Disord. 2014 Mar 13. [Epub ahead of print]

PMID:
24632989
[PubMed - as supplied by publisher]
18.

The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer's disease.

Adriaanse SM, van Dijk KR, Ossenkoppele R, Reuter M, Tolboom N, Zwan MD, Yaqub M, Boellaard R, Windhorst AD, van der Flier WM, Scheltens P, Lammertsma AA, Barkhof F, van Berckel BN.

Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1190-8. doi: 10.1007/s00259-014-2704-z. Epub 2014 Mar 11.

PMID:
24615466
[PubMed - in process]
19.

Optimizing patient care and research: the Amsterdam Dementia Cohort.

van der Flier WM, Pijnenburg YA, Prins N, Lemstra AW, Bouwman FH, Teunissen CE, van Berckel BN, Stam CJ, Barkhof F, Visser PJ, van Egmond E, Scheltens P.

J Alzheimers Dis. 2014;41(1):313-27. doi: 10.3233/JAD-132306.

PMID:
24614907
[PubMed - in process]
20.

Apraxia in mild cognitive impairment and Alzheimer's disease: validity and reliability of the van heugten test for apraxia.

Smits LL, Flapper M, Sistermans N, Pijnenburg YA, Scheltens P, van der Flier WM.

Dement Geriatr Cogn Disord. 2014;38(1-2):55-64. doi: 10.1159/000358168. Epub 2014 Mar 1.

PMID:
24603451
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk